- Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempicon April 25, 2025 at 6:07 pm
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn't have insurance coverage for the treatments.
- Merck lowers profit outlook, partly due to $200 million expected tariff hiton April 24, 2025 at 7:26 pm
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.
- Why we're lowering our Bristol Myers price target despite an earnings beat, guidance raiseon April 24, 2025 at 5:45 pm
Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.
- Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffson April 24, 2025 at 12:41 pm
The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.
- Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaroon April 24, 2025 at 1:02 am
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.
- FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snackson April 22, 2025 at 9:16 pm
The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.
- Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharmaon April 22, 2025 at 6:15 pm
Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.